ConductScience.org, home

Paper41009877

Epidemiological Trends of Carbapenemase-Producing Pseudomonas aeruginosa in a Tertiary Care Hospital in Athens, Greece, During 2020-2023.

Koumaki V and 6 others. Antibiotics (Basel), 2025. Cited by 0 papers, by iCite.

Cite this record

ConductScience Library. Epidemiological Trends of Carbapenemase-Producing Pseudomonas aeruginosa in a Tertiary Care Hospital in Athens, Greece, During 2020-2023. Papers, record 41009877. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41009877

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Epidemiological Trends of Carbapenemase-Producing Pseudomonas aeruginosa in a Tertiary Care Hospital in Athens, Greece, During 2020-2023.
PubMed
Journal
Antibiotics (Basel)
PubMed
Year
2025
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
0
iCite
Revised in PubMed
2025-09-30
PubMed

Authors7

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Koumaki VVasiliki
2Voudanta EEleni
3Michelaki AAikaterinihttps://orcid.org/0009-0003-3942-9293
4Orfanidou MMaria
5Vagiakou EEleni
6Vrioni GGeorgiahttps://orcid.org/0000-0003-4766-8238
7Tsakris AAthanasioshttps://orcid.org/0000-0003-0656-4715

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References28

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
136568831The Intriguing Carbapenemases of Pseudomonas aeruginosa: Current Status, Genetic Profile, and Global Epidemiology.Yale J Biol Med2022https://conductscience.org/library/papers/36568831PubMed
219797945Colistin in the 21st century.Curr Opin Infect Dis2009https://conductscience.org/library/papers/19797945PubMed
332875545
Treatment options for K. pneumoniae, P. aeruginosa and A. baumannii co-resistant to carbapenems, aminoglycosides, polymyxins and tigecycline: an approach based on the mechanisms of resistance to carbapenems.
Infection2020https://conductscience.org/library/papers/32875545PubMed
424168643Carbapenemase-producing Pseudomonas aeruginosa from central Greece: molecular epidemiology and genetic analysis of class I integrons.BMC Infect Dis2013https://conductscience.org/library/papers/24168643PubMed
538530465Multidrug-resistant organism bloodstream infection and hospital acquisition among inpatients in three tertiary Greek hospitals during the COVID-19 era.Eur J Clin Microbiol Infect Dis2024https://conductscience.org/library/papers/38530465PubMed
638352089Cefiderocol (Fetroja) as a Treatment for Hospital-Acquired Pneumonia.Cureus2024https://conductscience.org/library/papers/38352089PubMed
729872449How to manage Pseudomonas aeruginosa infections.Drugs Context2018https://conductscience.org/library/papers/29872449PubMed
836774938Global epidemiology and clinical outcomes of carbapenem-resistant Pseudomonas aeruginosa and associated carbapenemases (POP): a prospective cohort study.Lancet Microbe2023https://conductscience.org/library/papers/36774938PubMed
931492517Antibiotic resistance in Pseudomonas aeruginosa - Mechanisms, epidemiology and evolution.Drug Resist Updat2019https://conductscience.org/library/papers/31492517PubMed
1035240944Carbapenemase-producing Pseudomonas aeruginosa -an emerging challenge.Emerg Microbes Infect2022https://conductscience.org/library/papers/35240944PubMed
1134126951Burden of illness in US hospitals due to carbapenem-resistant Gram-negative urinary tract infections in patients with or without bacteraemia.BMC Infect Dis2021https://conductscience.org/library/papers/34126951PubMed
1227573251Colistin: still a lifesaver for the 21st century?Expert Opin Drug Metab Toxicol2017https://conductscience.org/library/papers/27573251PubMed
1323935307Mechanisms responsible for the emergence of carbapenem resistance in Pseudomonas aeruginosa.Hippokratia2012https://conductscience.org/library/papers/23935307PubMed
1430895216Geographic and Temporal Patterns of Antimicrobial Resistance in Pseudomonas aeruginosa Over 20 Years From the SENTRY Antimicrobial Surveillance Program, 1997-2016.Open Forum Infect Dis2019https://conductscience.org/library/papers/30895216PubMed
1538534720Antimicrobial and Diagnostic Stewardship of the Novel β-Lactam/β-Lactamase Inhibitors for Infections Due to Carbapenem-Resistant Enterobacterales Species and Pseudomonas aeruginosa.Antibiotics (Basel)2024https://conductscience.org/library/papers/38534720PubMed
1634860333
Aminoglycoside or Polymyxin Monotherapy for Treating Complicated Urinary Tract Infections Caused by Extensively Drug-Resistant Pseudomonas aeruginosa: A Propensity Score-Adjusted and Matched Cohort Study.
Infect Dis Ther2022https://conductscience.org/library/papers/34860333PubMed
1739200062Rapid Reversal of Carbapenemase-Producing Pseudomonas aeruginosa Epidemiology from blaVIM- to blaNDM-harbouring Isolates in a Greek Tertiary Care Hospital.Antibiotics (Basel)2024https://conductscience.org/library/papers/39200062PubMed
1837764003First Detection and Molecular Characterization of Pseudomonas aeruginosa blaNDM-1 ST308 in Greece.Microorganisms2023https://conductscience.org/library/papers/37764003PubMed
1910699045Outbreak of infections caused by Pseudomonas aeruginosa producing VIM-1 carbapenemase in Greece.J Clin Microbiol2000https://conductscience.org/library/papers/10699045PubMed
2033260774Unravelling the Features of Success of VIM-Producing ST111 and ST235 Pseudomonas aeruginosa in a Greek Hospital.Microorganisms2020https://conductscience.org/library/papers/33260774PubMed

See all 28 referencesDownload CSV of references

Cited by1

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 0 citations.

PMIDTitleJournalYearIn Papers
42795678Multidrug-Resistant Bloodstream Infections Before and After COVID-19: A Temporal Assessment of Outcomes and Resistance Across Two Eras in a Non-COVID Intensive Care Unit-The MATURATE ICU Study.Microorganisms2026https://conductscience.org/library/papers/42795678

Source PubMed

Download CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
VIM7431PubTator's text mininghttps://conductscience.org/library/genes/7431

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/41009877

GET https://conductscience.org/api/papers/v1/41009877/references?page=2